Effects of Nicorandil Administration on Infarct Size in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial

Effects of Nicorandil Administration on Infarct Size in Patients With ST‐Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The CHANGE Trial

Background Nicorandil was reported to improve microvascular dysfunction and reduce reperfusion injury when administered before primary percutaneous coronary intervention. In this multicenter, prospective, randomized, double‐blind clinical trial (CHANGE [Effects of Nicorandil Administration on Infarc...

Full description

Bibliographic Details
Main Authors: Geng Qian, Ying Zhang, Wei Dong, Zi‐Chao Jiang, Tao Li, Liu‐Quan Cheng, Yu‐Ting Zou, Xiao‐Si Jiang, Hao Zhou, Xin A, Ping Li, Mu‐Lei Chen, Xi Su, Jin‐Wen Tian, Bei Shi, Zong‐Zhuang Li, Yan‐Qing Wu, Yong‐Jun Li, Yun‐Dai Chen
Format: Article
Language:English
Published: Wiley 2022-09-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
cardiac catheterization
cardiac imaging techniques
nicorandil
prospective studies
ST elevation myocardial infarction
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.122.026232

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.026232

Similar Items